You are here: Home » PTI Stories » National » News
Business Standard

Jubilant Cadista recalls over 5,700 bottles of anti-depressant drug from US

Press Trust of India  |  New Delhi 

US-based is recalling over 5,700 bottles of Hydrochloride extended-release tablets, used to treat major depressive disorder, from the US market.

The company is a fully-owned subsidiary of Cadista Holdings Inc, which is a part of the Noida-based

As per the latest Enforcement Report issued by the US Food and Administration (USFDA), the Salisbury-based Jubilant Cadista is recalling the for "failed dissolution specifications".

The voluntary recall initiated by the company includes 3,072 bottles of 30 count and 2,688 bottles of 90 count.

The medicine was manufactured at

The USFDA said the product was distributed to one customer who may have further distributed the product.

A mail sent to the company to obtain comments remained unanswered.

In October 2018, had recalled over 1.58 lakh bottles of Pantoprazole Sodium delayed-release tablets, manufactured by at its Roorkee plant, from the and market.

In September 2018, the company had recalled over 46,000 bottles of tablets manufactured at the same plant.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Sun, March 17 2019. 11:05 IST